| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,853 | 3,448 | 3,328 | 3,385 | | Cost of Revenue | 1,715 | 1,643 | 1,669 | 1,571 | | | Gross Profit | 2,138 | 1,805 | 1,659 | 1,814 | | | Operating Expenses | | Research Development | 442 | 516 | 587 | 631 | | Selling General and Administrative | 2,377 | 2,200 | 2,266 | 2,239 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
| 6 | 6 | 6 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (681) | (917) | (1,200) | (1,062) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 1 |
-
| 6 | | Earnings Before Interest And Taxes | (681) | (916) | (1,200) | (1,056) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (681) | (916) | (1,200) | (1,056) | | Income Tax Expense | (4) | (42) | 3 | 12 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (677) | (874) | (1,203) | (1,068) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (677) | (874) | (1,203) | (1,068) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($677) | ($874) | ($1,203) | ($1,068) |
|
0.51% Nasdaq 
Income Statement
